{"id":48355,"date":"2022-09-14T13:01:56","date_gmt":"2022-09-14T11:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/"},"modified":"2022-09-14T13:01:56","modified_gmt":"2022-09-14T11:01:56","slug":"staar-surgical-patient-awareness-campaign-launched-in-new-york","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/","title":{"rendered":"STAAR Surgical Patient Awareness Campaign Launched In New York"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Joe Jonas and STAAR Host Media Day in NYC<\/i>\n<\/p>\n<p class=\"bwalignc\">\n<i>EVO ICL Patient Education Expanded to Social Media and YouTube with Millions of Views<\/i>\n<\/p>\n<p>LAKE FOREST, Calif.&#8211;(BUSINESS WIRE)&#8211;STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided an update on activities related to the commercial introduction of its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fus.discovericl.com%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=EVO+Visian%26%23174%3B+Implantable+Collamer%26%23174%3B+Lenses+%28EVO%29&amp;index=1&amp;md5=f217b4d1b180ca95a93b4280ae821661\" rel=\"nofollow noopener\" shape=\"rect\">EVO Visian\u00ae Implantable Collamer\u00ae Lenses (EVO)<\/a> in the U.S. EVO is an FDA-approved vision correction lens designed for the correction\/reduction of myopia with and without astigmatism. EVO was approved by the FDA on March 25, 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/5\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\"><\/a><\/p>\n<p>\nOn September 7, singer, songwriter, and actor Joe Jonas participated in a media day in New York City with several national news and media outlets to discuss how much his life has improved after his doctor recently implanted EVO lenses in his eyes. Following the media event, Joe Jonas posted messages and videos to his more than 34 million followers on various social media accounts, including <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fp%2FCiNBo6eL5Xd%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=Instagram&amp;index=2&amp;md5=5c9e648b7100a534543bbd8b60a35bc7\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fjoejonas%2Fstatus%2F1567483898086449160%3Fref_src%3Dtwsrc%255Egoogle%257Ctwcamp%255Eserp%257Ctwgr%255Etweet&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=Twitter&amp;index=3&amp;md5=cd06e5c738e2c1c91c512029ce1bfad4\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>, stating, \u201cI\u2019m thrilled to partner with EVO and talk about the amazing, life-changing new vision that I have. For those that are nearsighted like myself, I would have boxes of contacts in my bag for travelling, extras in my carry-on. Fast forward with the EVO procedure, I can see better than I\u2019ve ever seen \u2013 in fact, I\u2019m 20\/10! I genuinely feel like I was given bionic vision. I am so grateful I got EVO lenses.\u201d On September 13, ABC\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.goodmorningamerica.com%2Fculture%2Fvideo%2Fjoe-jonas-talks-struggles-myopia-undergoing-corrective-surgery-89802154&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=Good+Morning+America&amp;index=4&amp;md5=0edf9632ce5e97418959c169d5e65f7f\" rel=\"nofollow noopener\" shape=\"rect\">Good Morning America<\/a> featured a segment on Joe Jonas\u2019 journey to visual freedom with EVO lenses. Additional news and media outlets will also feature Joe\u2019s story. Later this month, STAAR will initiate an omni-channel EVO advertising campaign which will provide a glimpse into Jonas\u2019 journey to achieving visual freedom with EVO through a variety of settings in the star\u2019s everyday life.\n<\/p>\n<p>\nSTAAR and Joe Jonas previously announced their EVO partnership on August 10, 2022. On the same day, STAAR posted a series of five videos on YouTube, <b>\u201cMeet EVO ICL: Now Available in the US,\u201d<\/b> to educate and inform potential U.S. patients about the EVO procedure. The YouTube videos, each approximately four to six minutes in length, are listed below and available at the following links: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fc%2FEVOVisianICL&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.youtube.com%2Fc%2FEVOVisianICL&amp;index=5&amp;md5=789fde91bd62a80ca50fb32017378d9c\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.youtube.com\/c\/EVOVisianICL<\/a>.\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DajGr3iNyC1c&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=EVO+ICL%3A+The+High-Tech+Vision+Correction+Procedure+You+Need+to+Know+About&amp;index=6&amp;md5=ae13feceb4b93f3980fa4649c01015a0\" rel=\"nofollow noopener\" shape=\"rect\">EVO ICL: The High-Tech Vision Correction Procedure You Need to Know About<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DEyPaf81HtvQ&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=How+does+EVO+ICL+work%3F+Hint%3A+It+only+takes+about+30+minutes%21&amp;index=7&amp;md5=a8282854fab991925b398deb7f5d57a1\" rel=\"nofollow noopener\" shape=\"rect\">How does EVO ICL work? Hint: It only takes about 30 minutes!<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dt9ui9KWF_TQ%26t%3D10s&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=Nearsighted%3F+Learn+about+the+benefits+of+EVO+ICL%21&amp;index=8&amp;md5=315a5b843a0c80cca0be757cadbcc19e\" rel=\"nofollow noopener\" shape=\"rect\">Nearsighted? Learn about the benefits of EVO ICL!<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DAmFyyHAURPI%26t%3D3s&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=EVO+ICL+vs.+LASIK%3A+Know+Your+Vision+Solutions&amp;index=9&amp;md5=0be3fd626a787ceb16dcdec4fad13bbe\" rel=\"nofollow noopener\" shape=\"rect\">EVO ICL vs. LASIK: Know Your Vision Solutions<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DZHpysAESDjo%26t%3D1s&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=The+Results+Are+IN%3A+EVO+ICL+is+FDA-Approved%21&amp;index=10&amp;md5=bf4e644171488d0e00fd49161cfc1b71\" rel=\"nofollow noopener\" shape=\"rect\">The Results Are IN: EVO ICL is FDA-Approved!<\/a>\n<\/li>\n<\/ul>\n<p>\n\u201cThe initial stages of our U.S. EVO launch are focused on informing and educating potential patients about vision correction with EVO,\u201d said Caren Mason, President and CEO of STAAR Surgical. \u201cWe have certified hundreds of surgeons in the U.S. to perform the EVO procedure and are now commencing awareness and marketing activities. Our goal is to amplify the proven safety, effectiveness and patient satisfaction with our lenses in the U.S., demonstrating that a vision correction solution beyond glasses, contact lenses and LASIK exists. That solution is EVO.\u201d\n<\/p>\n<p>\nCertified EVO surgeons have been active on social media, including LinkedIn, sharing patient journeys to visual freedom with EVO. STAAR will introduce additional EVO patient ambassadors in the coming months, including a young NBA player and a Gen-Z actress, model and fashion icon. Other EVO patient ambassadors are also being introduced in key metropolitan areas. Already, EVO patients, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Freel%2FChIBc4-lCz-%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=model+India+Gants&amp;index=11&amp;md5=81ef83965087cda6dcbe00ea45682809\" rel=\"nofollow noopener\" shape=\"rect\">model India Gants<\/a>, winner of America\u2019s Next Top Model and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Freel%2FChScLQRDtzN%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=TV+chef+Jordan+Andino&amp;index=12&amp;md5=54286dfdb3bf666434cdcdaeec6fd4f7\" rel=\"nofollow noopener\" shape=\"rect\">TV chef Jordan Andino<\/a> have started sharing their positive EVO experience on social media accounts including Instagram and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tiktok.com%2F%40indiagants%2Fvideo%2F7136240967547358507%3Fis_from_webapp%3Dv1%26item_id%3D7136240967547358507&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=TikTok&amp;index=13&amp;md5=83d13f4800015437c2353c6a899a4500\" rel=\"nofollow noopener\" shape=\"rect\">TikTok<\/a>. Their enthusiastic sharing of the EVO experience adds more exciting and fun examples of the life enhancing visual freedom STAAR and its surgeon partners are excited to deliver to patients around the globe.\n<\/p>\n<p>\nFor more information about EVO Visian\u00ae Implantable Collamer\u00ae Lenses, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fus.discovericl.com%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=EVOICL.com&amp;index=14&amp;md5=d7d4b0f687c4428596220490b0918d16\" rel=\"nofollow noopener\" shape=\"rect\">EVOICL.com<\/a>.\n<\/p>\n<p>\n<b><span class=\"bwuline\">About STAAR Surgical<\/span><\/b>\n<\/p>\n<p>\nSTAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR\u2019s lens used in refractive surgery is called an Implantable Collamer\u00ae Lens or \u201cICL,\u201d which includes the EVO Visian ICL\u2122 product line. More than 2,000,000 Visian<sup>\u00ae<\/sup> ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fus.discovericl.com%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=EVOICL.com&amp;index=15&amp;md5=5a3d73229495bf52ab52af8899bdc784\" rel=\"nofollow noopener\" shape=\"rect\">EVOICL.com<\/a>. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.staar.com%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=www.staar.com&amp;index=16&amp;md5=47e843ceabfca313eae1393e5393e17c\" rel=\"nofollow noopener\" shape=\"rect\">www.staar.com<\/a>.\n<\/p>\n<p>\n<b><span class=\"bwuline\">Safe Harbor<\/span><\/b>\n<\/p>\n<p>\nAll statements that are not statements of historical fact are forward-looking statements, including statements about any of the following: product safety, effectiveness, or performance for any particular patient, and any statements of assumptions underlying any of the foregoing. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include risks factors set forth in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2021 under the caption \u201cRisk Factors,\u201d which is on file with the Securities and Exchange Commission and available in the \u201cInvestor Information\u201d section of the company\u2019s website under the heading \u201cSEC Filings.\u201d We disclaim any intention or obligation to update or revise any forward-looking statements due to new information or events. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements.\n<\/p>\n<p>\n<b><span class=\"bwuline\">Important Safety Information for EVO ICL<\/span><\/b>\n<\/p>\n<p>\nThe EVO Visian ICL lens is intended to correct\/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before. Since implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if your doctor determines that 1) the shape of your eye is not appropriate; 2) you do not meet the minimum endothelial cell density for your age at the time of implantation; 3) you have moderate to severe glaucoma; 4) your vision is not stable; or 5) if you are pregnant or nursing.\n<\/p>\n<p>\nFor additional information with potential benefits, risks and complications please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fus.discovericl.com%2F&amp;esheet=52894064&amp;newsitemid=20220914005180&amp;lan=en-US&amp;anchor=EVOICL.com&amp;index=17&amp;md5=b25eecdc7ca4b544011a15be6c84702c\" rel=\"nofollow noopener\" shape=\"rect\">EVOICL.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investors<\/b><br \/>Brian Moore<br \/>\n<br \/>Vice President, Investor, Media Relations and Corporate Development<br \/>\n<br \/>(626) 303-7902, Ext. 3023<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x62;&#x6d;&#x6f;&#x6f;&#x72;&#x65;&#x40;&#x73;&#x74;&#x61;&#x61;&#x72;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#98;&#109;&#x6f;&#x6f;&#114;&#101;&#x40;&#x73;&#116;&#97;&#x61;&#x72;&#46;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Media<\/b><br \/>Jen Jones<br \/>\n<br \/>Gold PR | Social Media<br \/>\n<br \/>(310) 918-4313<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#108;t&#x6f;&#58;j&#x6a;&#111;&#x6e;&#x65;s&#x40;&#103;o&#x6c;&#100;&#x70;&#x72;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#x6a;&#111;&#x6e;&#101;&#x73;&#64;&#x67;&#111;&#x6c;&#100;&#x70;&#114;&#x2e;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Joe Jonas and STAAR Host Media Day in NYC EVO ICL Patient Education Expanded to Social Media and YouTube with Millions of Views LAKE FOREST, Calif.&#8211;(BUSINESS WIRE)&#8211;STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided an update on activities related to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48355","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>STAAR Surgical Patient Awareness Campaign Launched In New York - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STAAR Surgical Patient Awareness Campaign Launched In New York - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Joe Jonas and STAAR Host Media Day in NYC EVO ICL Patient Education Expanded to Social Media and YouTube with Millions of Views LAKE FOREST, Calif.&#8211;(BUSINESS WIRE)&#8211;STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided an update on activities related to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-14T11:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"STAAR Surgical Patient Awareness Campaign Launched In New York\",\"datePublished\":\"2022-09-14T11:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/\"},\"wordCount\":1237,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005180\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/\",\"name\":\"STAAR Surgical Patient Awareness Campaign Launched In New York - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005180\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\",\"datePublished\":\"2022-09-14T11:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005180\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005180\\\/en\\\/683092\\\/21\\\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/staar-surgical-patient-awareness-campaign-launched-in-new-york\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STAAR Surgical Patient Awareness Campaign Launched In New York\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STAAR Surgical Patient Awareness Campaign Launched In New York - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/","og_locale":"en_US","og_type":"article","og_title":"STAAR Surgical Patient Awareness Campaign Launched In New York - Pharma Trend","og_description":"Joe Jonas and STAAR Host Media Day in NYC EVO ICL Patient Education Expanded to Social Media and YouTube with Millions of Views LAKE FOREST, Calif.&#8211;(BUSINESS WIRE)&#8211;STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided an update on activities related to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-14T11:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"STAAR Surgical Patient Awareness Campaign Launched In New York","datePublished":"2022-09-14T11:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/"},"wordCount":1237,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/","url":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/","name":"STAAR Surgical Patient Awareness Campaign Launched In New York - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","datePublished":"2022-09-14T11:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220914005180\/en\/683092\/21\/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/staar-surgical-patient-awareness-campaign-launched-in-new-york\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"STAAR Surgical Patient Awareness Campaign Launched In New York"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48355"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48355\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}